Id |
Subject |
Object |
Predicate |
Lexical cue |
ForCovid19 |
tao:has_database_id |
T52 |
0-9 |
Interrupt |
denotes |
Hijacking |
|
|
T7 |
10-20 |
Species |
denotes |
SARS-CoV-2 |
|
Tax:2697049 |
T17 |
21-25 |
Gene |
denotes |
ACE2 |
|
Gene:59272 |
T51 |
35-46 |
Bind |
denotes |
Interaction |
|
|
T26 |
77-86 |
Chemical |
denotes |
Steroidal |
drug |
D013256 |
T21 |
130-153 |
Biological |
denotes |
Receptor Binding Domain |
|
|
T3 |
159-183 |
Disease |
denotes |
coronavirus disease 2019 |
|
MESH:C000657245 |
T1 |
185-193 |
Disease |
denotes |
COVID-19 |
|
MESH:C000657245 |
T25 |
200-227 |
Disease |
denotes |
respiratory tract infection |
|
D012141 |
T6 |
242-300 |
Species |
denotes |
severe acute respiratory syndrome coronavirus (SARS)-CoV-2 |
|
Tax:2697049 |
T30 |
459-477 |
Chemical |
denotes |
natural substances |
drug |
|
T31 |
482-508 |
Chemical |
denotes |
clinically available drugs |
drug |
|
T4 |
527-538 |
Species |
denotes |
SARS-CoV2-2 |
|
Tax:2697049 |
T37 |
638-655 |
Biological |
denotes |
druggable pockets |
|
|
T38 |
671-691 |
Biological |
denotes |
central β-sheet core |
|
|
T8 |
699-709 |
Species |
denotes |
SARS-CoV-2 |
|
Tax:2697049 |
T23 |
710-725 |
Gene |
denotes |
Spike's protein |
|
Gene:43740568 |
T10 |
726-749 |
Biological |
denotes |
receptor binding domain |
|
|
T11 |
751-754 |
Biological |
denotes |
RBD |
|
|
T35 |
773-782 |
Condition |
denotes |
in silico |
|
|
T28 |
861-873 |
Chemical |
denotes |
triterpenoid |
drug |
D014315 |
T27 |
874-883 |
Chemical |
denotes |
steroidal |
drug |
D013256 |
T32 |
896-903 |
Interrupt |
denotes |
inhibit |
|
|
T34 |
904-915 |
Bind |
denotes |
interaction |
|
|
T22 |
923-928 |
Gene |
denotes |
Spike |
|
Gene:43740568 |
T12 |
929-932 |
Biological |
denotes |
RBD |
|
|
T36 |
942-965 |
Biological |
denotes |
carboxypeptidase domain |
|
|
T20 |
973-1002 |
Gene |
denotes |
Angiotensin Converting Enzyme |
|
Gene:59272 |
T16 |
1004-1008 |
Gene |
denotes |
ACE2 |
|
Gene:59272 |
T13 |
1084-1087 |
Biological |
denotes |
RBD |
|
|
T5 |
1095-1105 |
Species |
denotes |
SARS CoV-2 |
|
Tax:2697049 |
T24 |
1106-1119 |
Gene |
denotes |
Spike protein |
|
Gene:43740568 |
T14 |
1183-1186 |
Biological |
denotes |
RBD |
|
|
T18 |
1202-1206 |
Gene |
denotes |
ACE2 |
|
Gene:59272 |
T29 |
1272-1285 |
Chemical |
denotes |
triterpenoids |
drug |
D014315 |
T41 |
1294-1308 |
Chemical |
denotes |
glycyrrhetinic |
|
D006034 |
T42 |
1313-1328 |
Chemical |
denotes |
oleanolic acids |
|
D009828 |
T39 |
1323-1328 |
Chemical |
denotes |
acids |
|
D006034 |
T40 |
1363-1373 |
Chemical |
denotes |
bile acids |
|
MESH:D001647 |
T44 |
1363-1373 |
Chemical |
denotes |
bile acids |
|
|
T43 |
1384-1404 |
Chemical |
denotes |
amidated derivatives |
|
|
T46 |
1413-1418 |
Glycan |
denotes |
glyco |
|
|
T45 |
1419-1439 |
Chemical |
denotes |
ursodeoxycholic acid |
|
MESH:D014580 |
T48 |
1444-1470 |
Chemical |
denotes |
semi-synthetic derivatives |
|
|
T47 |
1479-1495 |
Chemical |
denotes |
obeticholic acid |
|
MESH:C464660 |
T49 |
1496-1503 |
NegativeRegulation |
denotes |
reduces |
|
|
T15 |
1508-1511 |
Biological |
denotes |
RBD |
|
|
T19 |
1512-1516 |
Gene |
denotes |
ACE2 |
|
Gene:59272 |
T50 |
1517-1524 |
Bind |
denotes |
binding |
|
|
T2 |
1595-1603 |
Disease |
denotes |
COVID-19 |
|
MESH:C000657245 |
T9 |
1613-1623 |
Species |
denotes |
SARS-CoV-2 |
|
Tax:2697049 |
T33 |
1630-1640 |
Chemical |
denotes |
inhibitors |
inhibitor|drug |
|
R1 |
T1 |
T3 |
abbreviation |
COVID-19,coronavirus disease 2019 |
R10 |
T32 |
T34 |
is_a |
inhibit,interaction |
R11 |
T5 |
T24 |
of_a |
SARS CoV-2,Spike protein |
R12 |
T22 |
T12 |
of_a |
Spike,RBD |
R13 |
T24 |
T13 |
of_a |
Spike protein,RBD |
R14 |
T32 |
T35 |
has_status |
inhibit,in silico |
R15 |
T11 |
T10 |
abbreviation |
RBD,receptor binding domain |
R16 |
T8 |
T23 |
of_a |
SARS-CoV-2,Spike's protein |
R17 |
T23 |
T10 |
of_a |
Spike's protein,receptor binding domain |
R18 |
T10 |
T38 |
of_a |
receptor binding domain,central β-sheet core |
R19 |
T38 |
T37 |
of_a |
central β-sheet core,druggable pockets |
R2 |
T6 |
T3 |
cause_of |
severe acute respiratory syndrome coronavirus (SARS)-CoV-2,coronavirus disease 2019 |
R20 |
T20 |
T36 |
of_a |
Angiotensin Converting Enzyme,carboxypeptidase domain |
R21 |
T41 |
T39 |
- |
glycyrrhetinic,acids |
R22 |
T46 |
T45 |
with |
glyco,ursodeoxycholic acid |
R23 |
T44 |
T43 |
- |
bile acids,amidated derivatives |
R24 |
T15 |
T50 |
of_a |
RBD,binding |
R25 |
T19 |
T50 |
to |
ACE2,binding |
R26 |
T49 |
T50 |
is_a |
reduces,binding |
R27 |
T29 |
T49 |
is_a |
triterpenoids,reduces |
R28 |
T41 |
T49 |
is_a |
glycyrrhetinic,reduces |
R29 |
T42 |
T49 |
is_a |
oleanolic acids,reduces |
R3 |
T25 |
T3 |
is_a |
respiratory tract infection,coronavirus disease 2019 |
R30 |
T40 |
T49 |
is_a |
bile acids,reduces |
R31 |
T44 |
T49 |
is_a |
bile acids,reduces |
R32 |
T45 |
T49 |
is_a |
ursodeoxycholic acid,reduces |
R33 |
T48 |
T49 |
is_a |
semi-synthetic derivatives,reduces |
R34 |
T47 |
T49 |
is_a |
obeticholic acid,reduces |
R35 |
T9 |
T2 |
cause_of |
SARS-CoV-2,COVID-19 |
R36 |
T2 |
T33 |
against |
COVID-19,inhibitors |
R37 |
T4 |
T31 |
against |
SARS-CoV2-2,clinically available drugs |
R38 |
T4 |
T30 |
against |
SARS-CoV2-2,natural substances |
R39 |
T7 |
T51 |
is_a |
SARS-CoV-2,Interaction |
R4 |
T16 |
T20 |
abbreviation |
ACE2,Angiotensin Converting Enzyme |
R40 |
T17 |
T51 |
to |
ACE2,Interaction |
R41 |
T26 |
T52 |
is_a |
Steroidal,Hijacking |
R42 |
T52 |
T51 |
is_a |
Hijacking,Interaction |
R5 |
T28 |
T32 |
is_a |
triterpenoid,inhibit |
R6 |
T27 |
T32 |
is_a |
steroidal,inhibit |
R7 |
T22 |
T34 |
is_a |
Spike,interaction |
R8 |
T20 |
T34 |
to |
Angiotensin Converting Enzyme,interaction |